Related Experiment Video
Updated: Jan 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Longitudinal changes and borderline reclassification of Lipoprotein(a) compared with conventional lipids in over
Da-Eun Sung1, Mi-Yeon Lee2, Min-Jung Kwon3
1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Background And Aims:
Lipoprotein(a) [Lp(a)] is a genetically determined cardiovascular risk factor. Although generally considered stable, data on intra-individual reclassification of Lp(a) categories over time compared with conventional lipid markers remain limited, particularly in East Asian populations.
Methods:
We conducted a retrospective cohort study including 230,018 Korean adults (mean age, 38·5 years; 51·4 % male) who underwent routine health examinations with at least two Lp(a) measurements between July 1, 2015, and December 30, 2022. Individuals with a history of coronary artery disease or those receiving lipid-lowering therapy were excluded. The primary outcomes were intraclass correlation coefficients (ICCs), reclassification rates across predefined Lp(a) categories (<30, 30-50, 50-100, and ≥100 mg/dL), and comparisons with traditional lipid parameters.
Results:
Lp(a) demonstrated excellent reproducibility (ICC ≥0·99) and greater long-term stability than LDL-C, ApoB, and triglycerides. Among participants with baseline Lp(a) levels <30 mg/dL or ≥100 mg/dL, 93 % and 91 % remained in the same category at follow-up, respectively. However, among those with baseline Lp(a) levels of 30-50 mg/dL, 35 % transitioned to higher-risk categories, as did 19 % of those with levels of 50-100 mg/dL. By comparison, 28 % of individuals with LDL-C ≥160 mg/dL and 22 % with triglycerides ≥200 mg/dL moved to lower categories during follow-up.
Conclusions:
Lp(a) demonstrates greater stability than conventional lipid markers. While a single measurement may suffice for clearly low (<30 mg/dL) or high (≥100 mg/dL) Lp(a) levels, periodic reassessment may be clinically warranted for individuals in intermediate Lp(a) levels (30-100 mg/dL).
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Longitudinal Research

